Q4 2023 Holdings
Filed 2024-02-13 | 27 holdings | $1.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $263.3M | 3,577,267 | 25.2% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $117.0M | 10,473,913 | 11.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $109.5M | 3,904,319 | 10.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $77.0M | 1,332,545 | 7.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $75.1M | 324,619 | 7.2% |
| Savara Inc(SVRA) | COM | 805111101 | $66.9M | 14,232,751 | 6.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $45.4M | 2,000,000 | 4.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $36.6M | 8,061,719 | 3.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $31.9M | 1,112,396 | 3.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $28.6M | 2,892,663 | 2.7% |
| Natera Inc(NTRA) | COM | 632307104 | $25.1M | 400,197 | 2.4% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $21.4M | 2,749,808 | 2.1% |
| Mersana Therapeutics Inc | COM | 59045L106 | $20.1M | 8,663,673 | 1.9% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $19.2M | 3,130,422 | 1.8% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $18.8M | 1,822,883 | 1.8% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $15.6M | 1,431,058 | 1.5% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $14.2M | 16,915,784 | 1.4% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $9.7M | 3,000,000 | 0.9% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $9.3M | 1,642,210 | 0.9% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $7.6M | 1,937,207 | 0.7% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $7.6M | 2,485,638 | 0.7% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $6.2M | 8,434,560 | 0.6% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $6.0M | 2,000,000 | 0.6% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $5.7M | 1,331,801 | 0.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.7M | 3,500,000 | 0.4% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $1.5M | 2,805,413 | 0.1% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $313.0K | 100,000 | 0.0% |